European Journal of Pediatrics

, Volume 163, Issue 3, pp 135–139

Paroxetine during breast-feeding: infant weight gain and maternal adherence to counsel

Original Paper

Abstract

The aims of the present study were to examine the weight gain in infants breast fed by mothers taking paroxetine and to assess the clinical implementation of the recommendations of the teratology service in our centre. A prospective cohort study design was used. The study group included 27 mothers who had taken paroxetine for at least 2 weeks while breast-feeding, 19 mothers who did not taken paroxetine and did not breast-feed their infants, and 27 mothers who breast fed their infants but did not take any drugs. Participants completed a detailed outcome questionnaire at 3 months to 1 year after the birth of their child. Additional infant data were obtained from specific follow-up forms routinely completed by the paediatricians and nurses at well baby clinics and paediatric services in Israel. Infant weight and developmental milestones at ages 3, 6, and 12 months were recorded. There were no statistically significant differences between the paroxetine group and control groups in mean infant weight at ages 6 and 12 months. The usual developmental milestones were reached in all groups. There were no reported adverse effects of paroxetine during lactation except for irritability in one infant. Mothers expressed satisfaction with the treatment. Conclusion:paroxetine use during breast-feeding does not affect infant weight gain and rarely has adverse effects on the infant. Paroxetine may be an acceptable solution for depression in lactating women provided that they adhere to four important restrictions: use lowest dose (20 mg/day), preferable single bed-time dose, avoid combinations of drugs, and ensure close medical follow-up of the infant.

Keywords

Adverse effects Breast-feeding Paroxetine Weight gain 

Abbreviations

BELTIS

Beilinson Teratology Information Service

SSRI

selective serotonin reuptake inhibitor

References

  1. 1.
    Begg EJ, Duffull SB, Saunders DA, Buttimore RC, Ilett KF, Hackett LP, Yapp P, Wilson DA (1999) Paroxetine in human milk. Br J Clin Pharmacol 48: 142–147CrossRefPubMedGoogle Scholar
  2. 2.
    Chambers CD, Anderson PD, Thomas RG, Dick LM, Felix RJ, Johnson KA, Jones KL (1999) Weight gain in infants breastfed by mothers who take fluoxetine. Pediatrics 104: e61PubMedGoogle Scholar
  3. 3.
    Hale T (2002) Medications and mothers’ milk. Pharmasoft Publishing, Amarillo, TexasGoogle Scholar
  4. 4.
    Hendrick V, Smith LM, Hwang S, Altshuler LL, Haynes D (2003) Weight gain in breastfed infants of mothers taking antidepressant medication. J Clin Psychiatry 64: 410–412PubMedGoogle Scholar
  5. 5.
    Misri S, Carter D, Ryan DM (1999) Paroxetine levels in mother/infant dyad. Annual Meeting Syllabus and Proceedings Summary. American Psychiatric Association, Washington, p 100Google Scholar
  6. 6.
    Moldovan Costei A, Kozer E, Ho T, Ito S, Koren G (2002) Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 156: 1129–1132PubMedGoogle Scholar
  7. 7.
    O’Hara MW, Swain AM (1996) Rates and risk of postpartum depression – a meta-analysis. Int Rev Psychiatry 8: 37–54Google Scholar
  8. 8.
    Öhman R, Hägg S, Carleborg L, Spigset O (1999) Excretion of paroxetine into breast milk. J Clin Psychiatry 60: 519–523PubMedGoogle Scholar
  9. 9.
    Spigset O, Carleborg L, Norström A, Sandlund M (1996) Paroxetine level in breast milk. J Clin Psychiatry 57: 39Google Scholar
  10. 10.
    Stowe ZN, Cohen LS, Hostetter A, Ritchie JC, Owens MJ, Nemeroff CB (2000) Paroxetine in human milk and nursing infants. Am J Psychiatry 157: 185–189CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Paul Merlob
    • 1
    • 2
    • 3
  • Bracha Stahl
    • 2
    • 3
  • Jaqueline Sulkes
    • 3
    • 4
  1. 1.Department of NeonatologyRabin Medical Centre, Beilinson CampusPetah Tiqwa Israel
  2. 2.Beilinson Teratology Information Service (BELTIS)Rabin Medical Centre, Beilinson CampusPetah Tiqwa Israel
  3. 3.Sackler School of MedicineTel-aviv UniversityTel-avivIsrael
  4. 4.Epidemiology UnitRabin Medical Centre, Beilinson CampusPetah Tiqwa Israel

Personalised recommendations